Form 483

Sarah H. Lisanby, M.D. Form 483, 2012-10-29

FDA issued a Form 483 to Sarah H. Lisanby, M.D. on 2012-10-29 with 6 public-safe observations.

483· Form 483 issued6 observations

Sarah H. Lisanby, M.D. · New York, United States · Issued October 29, 2012

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Oct 2012
21 CFR 812.43(c)

No investigator agreement

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.43(c)(1)

No curriculum vitae in investigator agreement

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.100

Investigator lack of informed consent

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.100

Investigator non-compliance with agreement/plan/regulations

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.140(a)(4)

Investigator protocol records inadequate

Cited by Eileen J Bannerman

Inspected site

SHSarah H. Lisanby, M.D.New York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 812.100Cited across public-safe Form 483 observations2x
21 CFR 812.140(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 812.140(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 812.43(c)Cited across public-safe Form 483 observations1x
21 CFR 812.43(c)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere